Carrie A. Blanchette, Ph.D.
Affiliations: | 2007 | Duke University, Durham, NC |
Area:
Genetics, OncologyGoogle:
"Carrie Blanchette"Parents
Sign in to add mentorJeffrey R. Marks | grad student | 2007 | Duke | |
(Examination of Aurora-A kinase in breast cancer and identification of Spt5 as a putative substrate.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bennett CB, Westmoreland TJ, Verrier CS, et al. (2008) Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction. Plos One. 3: e1448 |
Lancaster JM, Sayer RA, Blanchette C, et al. (2006) High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels International Journal of Gynecological Cancer. 16: 1529-1535 |
Shao R, Bao S, Bai X, et al. (2004) Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Molecular and Cellular Biology. 24: 3992-4003 |
Tebbit CL, Marks JR, Dressman H, et al. (2004) Gene expression signature characterizing cyclin E protein overexpression in primary breast tumors Journal of the American College of Surgeons. 199: 78-79 |
Lancaster JM, Sayer R, Blanchette C, et al. (2003) High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival Clinical Cancer Research. 9: 762-766 |
Spang R, Zuzan H, West M, et al. (2002) Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biology. 2: 369-81 |
West M, Blanchette C, Dressman H, et al. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 98: 11462-7 |